Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer

Mutlu H., Musri F., Artac M., KARGI A., OZDOGAN M., BOZCUK H.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.11, sa.2, ss.287-290, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4103/0973-1482.154008
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.287-290
  • Anahtar Kelimeler: Breast cancer, heavily treated, metronomic, survival, PHASE-III TRIAL, CYCLOPHOSPHAMIDE, COMBINATION, CAPECITABINE, BENEFIT, ANTHRACYCLINE, BEVACIZUMAB, ETOPOSIDE, SURVIVAL, DOXORUBICIN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: We aimed to assess the efficacy of a metronomic regimen with cyclophosphamide and etoposide in heavily treated patients with metastatic breast cancer (MBC).